随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
The fifth tactic involves building multi-platform authority by publishing consistent information across different channels. AI models, particularly those with web search capabilities, often cross-reference information across sources to verify accuracy and assess credibility. When they find the same core information presented consistently on your website, in your social media content, in articles you've published elsewhere, and in your responses on community platforms, it signals that you're a legitimate authority on that topic.，推荐阅读同城约会获取更多信息
A10 的底盘结构是前麦弗逊、后扭力梁。这并不意外，扭力梁结构简单、占用空间小，是小车的标准答案。不一样的是，零跑把扭力梁带来的空间优势发挥到了极致。，详情可参考服务器推荐
第四十六条 发生核事故时，有关单位和个人必须立即采取应急措施，并按照有关法律、行政法规的规定报告，禁止缓报、瞒报、谎报核事故。，推荐阅读同城约会获取更多信息
Nature, Published online: 25 February 2026; doi:10.1038/s41586-026-10149-8